Stryker Neurovascular
Open enrollment with a later-stage pipeline tilt
According to ClinicalTrials.gov-derived indexes, Stryker Neurovascular sits in the top decile of US sponsors by registered trial count (#1,049 of 15,742 sponsors by registered trial count).
Stryker Neurovascular: 13 sponsored US clinical trials, 1 recruiting.
Stryker Neurovascular sponsors 13 registered US clinical trials on ClinicalTrials.gov, 1 of them currently recruiting, and 10 completed. 1 of these trials are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Aneurysm, Intracranial, with 2 trials.
Top-decile sponsor footprint
Stryker Neurovascular ranks in the top decile of sponsors by registered trial count (#1,049 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
10 of 10 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (100.0%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
13 total, page 1 of 1
Safety and Efficacy of Endovascular Treatment of Intracranial Aneurysms With Surpass Elite With GUARDian Flow Diverter (GUARD)
NCT06872684
Evaluation of Safety and Effectiveness of Stryker Surpass Evolve™ Flow Diverter System
NCT04195568
Citadel Embolization Device Study
NCT04057352
ASSIST Registry Studying Various Operator Techniques
NCT03845491
Neuroform Atlas Stent System Study
NCT02340585
Clinical Mismatch in the Triage of Wake Up and Late Presenting Strokes Undergoing Neurointervention With Trevo
NCT02142283
TransForm™ Occlusion Balloon Catheter Registry
NCT01949779
Post Market Surveillance Study of the Wingspan Stent System
NCT02034058
Trevo® Retriever Registry Post Market Surveillance
NCT02040259
Safety and Effectiveness of an Intracranial Aneurysm Embolization System for Treating Large or Giant Wide Neck Aneurysms
NCT01716117
Randomized Trial Evaluating Performance of the Trevo Retriever Versus the Merci Retriever in Acute Ischemic Stroke
NCT01270867
Merci Registry - Real World Use of the Merci Retrieval System in Acute Ischemic Stroke
NCT00478478
MAPS Trial: Matrix And Platinum Science
NCT00396981
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 4 | 1 |
Therapeutic Areas
Where Stryker Neurovascular enrollment is open (later-stage tilt)
1 recruiting of 13 indexed (8% open); 10 completed (77%).
Phase mix: 1 late (III/IV) vs 0 early (I/II) (later-stage heavy).
Top condition: Aneurysm, Intracranial (2 trials), 4 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Stryker Neurovascular: open-pipeline peers nationwide
Peers matched on 13 registered trials and 8% open enrollment, not the therapeutic-area sidebar.
Stryker Neurovascular sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 13 trials (± recruiting share)
- Adaptimmune · 13 trials · 0% recruiting
- Agennix · 13 trials · 0% recruiting
- Akili Interactive Labs · 13 trials · 0% recruiting
- Alumis · 13 trials · 8% recruiting
Sponsors near 8% open enrollment (± trial volume)
- Andrei Iagaru · 8% recruiting · 13 trials
- BioXcel Therapeutics · 8% recruiting · 13 trials
- Corporal Michael J. Crescenz VA Medical Center · 8% recruiting · 13 trials
- Fresenius Medical Care North America · 8% recruiting · 13 trials
Related
What to do with this Stryker Neurovascular page
13 registered trials is a research-attention snapshot, not an endorsement of Stryker Neurovascular or any single study.
- 1 of Stryker Neurovascular's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Aneurysm, Intracranial is the condition Stryker Neurovascular studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Aneurysm, Intracranial trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Stryker Neurovascular pipeline card: 13 registered trials from official public datasets.Report a data error.